Parkman R, Rosen F S, Rappeport J, Camitta B, Levey R L, Nathan D G
Transplantation. 1976 Feb;21(2):110-6. doi: 10.1097/00007890-197602000-00004.
Five patients with aplastic anemia were shown to be sensitized in vivo to the transplantation antigens of HL-A identical and MLC nonreactive sibling bone marrow transplantation donors. The sensitization in four cases were detected by antibody-dependent cell-mediated lysis (AICML) techniques, and in one case by antibody-dependent cell-mediated lysis (ADCML). In two cases the inherited nature of the sensitizing antigen was demonstrated, and in one case the inheritance of the antigen was shown by a family study to be independent of the HL-A and MLC loci. Maximal AICML was demonstrated in two cases at the time of bone marrow graft rejection. Successful transplants after immunosuppression with rabbit anti-thymocyte serum, procarbazine, and cyclophosphamide were performed in two patients, in whom sensitization was detected before transplantation.
五例再生障碍性贫血患者被证明在体内对HL-A相同且混合淋巴细胞培养无反应的同胞骨髓移植供者的移植抗原敏感。四例患者的致敏情况通过抗体依赖细胞介导的细胞溶解(AICML)技术检测到,一例通过抗体依赖细胞介导的细胞溶解(ADCML)检测到。两例患者显示了致敏抗原的遗传特性,一例患者通过家族研究表明该抗原的遗传与HL-A和混合淋巴细胞培养位点无关。两例患者在骨髓移植排斥时表现出最大程度的AICML。两名在移植前检测到致敏的患者在使用兔抗胸腺细胞血清、丙卡巴肼和环磷酰胺进行免疫抑制后成功进行了移植。